Lolie Yu
Pediatric Hematology-Oncology · New Orleans, LANPI 1063433084
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,509 and has fallen 95.6% since, to $66 in 2025.
Across 110 payments — averaging $29.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$753
- Servier Pharmaceuticals LLC$405
- Novartis$322
- CSL Behring$195
- Novo Nordisk$194
- Sobi, Inc$187
- plus $1K from 22 others
Across 73 payments — averaging $3831.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$215K
- Astellas Pharma Global Development$23K
- Astellas US Technologies$17K
- E.r. Squibb & Sons, L.L.C.$12K
- National Marrow Donor Program$12K
- Novartis$2K
What the payments were for
- Consulting fees$371%
- Food & beverage$3,14796%
- Education$983%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 9 | $753 |
| Servier Pharmaceuticals LLC | 12 | $405 |
| Novartis | 19 | $322 |
| CSL Behring | 9 | $195 |
| Novo Nordisk | 10 | $194 |
| Sobi, Inc | 7 | $187 |
| BTG International Inc. | 3 | $140 |
| Seagen Inc. | 3 | $140 |
| AstraZeneca(2 entities) | 6 | $114 |
| Bioverativ Therapeutics Inc. | 1 | $110 |
| Octapharma USA, Inc. | 4 | $104 |
| EMD Serono, Inc. | 1 | $100 |
| Pfizer | 5 | $97 |
| Genentech USA, Inc. | 2 | $69 |
| Emmaus Medical, Inc. | 3 | $55 |
| Global Blood Therapeutics, Inc. | 3 | $51 |
| HEMA Biologics, LLC | 2 | $50 |
| Fennec Pharmaceuticals, Inc. | 1 | $28 |
| Genetix Biotherapeutics Inc | 1 | $21 |
| Epizyme, Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $19 |
| RARE Disease Therapeutics, Inc. | 1 | $18 |
| Bayer | 1 | $18 |
| Medexus Pharma, Inc. | 1 | $15 |
| USWM, LLC | 1 | $15 |
| Amgen | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $13 |
| Silvergate Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,282 in reported general payments places this provider in the 65th percentile of 26 pediatric hematology-oncology providers in Louisiana.
See all pediatric hematology-oncology providers in Louisiana →
Other pediatric hematology-oncology in New Orleans
- Tammuella Chrisentery-SingletonNew Orleans$1.4M
- Maria Velez-YanguasNew Orleans$105K
- Zachary LeblancNew Orleans$55K
- Dana LeblancNew Orleans$25K
- Renee GardnerNew Orleans$25K
- Pinki PrasadNew Orleans$20K
- Robert VasquezNew Orleans$6K
- Craig LottermanNew Orleans$3K
- Cori MorrisonNew Orleans$1K
- Justin FargeNew Orleans$797
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.